These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9867074)

  • 1. Inhibition of lipolysis reduces beta1-adrenoceptor-mediated thermogenesis in man.
    Schiffelers SL; Brouwer EM; Saris WH; van Baak MA
    Metabolism; 1998 Dec; 47(12):1462-7. PubMed ID: 9867074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dobutamine as selective beta(1)-adrenoceptor agonist in in vivo studies on human thermogenesis and lipid utilization.
    Schiffelers SL; van Harmelen VJ; de Grauw HA; Saris WH; van Baak MA
    J Appl Physiol (1985); 1999 Sep; 87(3):977-81. PubMed ID: 10484566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
    Segerlantz M; Bramnert M; Manhem P; Laurila E; Groop LC
    Eur J Endocrinol; 2003 Dec; 149(6):511-9. PubMed ID: 14640991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat oxidation after acipimox-induced reduction in plasma nonesterified fatty acids during exercise at 0 degrees C and 20 degrees C.
    Layden JD; Malkova D; Nimmo MA
    Metabolism; 2004 Sep; 53(9):1131-5. PubMed ID: 15334373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of beta1- and beta2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans.
    Hoeks J; van Baak MA; Hesselink MK; Hul GB; Vidal H; Saris WH; Schrauwen P
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E775-82. PubMed ID: 12824081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta(1)- and beta(2)-Adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men.
    Schiffelers SL; Saris WH; Boomsma F; van Baak MA
    J Clin Endocrinol Metab; 2001 May; 86(5):2191-9. PubMed ID: 11344226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reduction in postprandial lipemia after exercise is independent of the relative contributions of fat and carbohydrate to energy metabolism during exercise.
    Malkova D; Hardman AE; Bowness RJ; Macdonald IA
    Metabolism; 1999 Feb; 48(2):245-51. PubMed ID: 10024090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of an increased free fatty acid concentration on thermogenesis and substrate oxidation in obese and lean men.
    Schiffelers SL; Saris WH; van Baak MA
    Int J Obes Relat Metab Disord; 2001 Jan; 25(1):33-8. PubMed ID: 11244455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability of glucose ingested during muscle exercise performed under acipimox-induced lipolysis blockade.
    Gautier JF; Pirnay F; Jandrain B; Lacroix M; Mosora F; Scheen AJ; Cathelineau G; Lefèbvre PJ
    Eur J Appl Physiol Occup Physiol; 1994; 68(5):406-12. PubMed ID: 8076620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effect of decreasing nonesterified fatty acid levels with acipimox in hyperthyroid patients.
    Park KS; Kim CH; Lee MK; Shin CS; Park DJ; Kim SY; Cho BY; Lee HK
    Metabolism; 1999 Oct; 48(10):1318-21. PubMed ID: 10535397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of beta 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans.
    Liu YL; Toubro S; Astrup A; Stock MJ
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):678-85. PubMed ID: 8574280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute metabolic and hormonal responses to the inhibition of lipolysis in non-obese patients with non-insulin-dependent (type 2) diabetes mellitus: effects of acipimox.
    Fulcher GR; Walker M; Catalano C; Farrer M; Alberti KG
    Clin Sci (Lond); 1992 May; 82(5):565-71. PubMed ID: 1317767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of adipose tissue lipolysis increases intramuscular lipid use in type 2 diabetic patients.
    van Loon LJ; Manders RJ; Koopman R; Kaastra B; Stegen JH; Gijsen AP; Saris WH; Keizer HA
    Diabetologia; 2005 Oct; 48(10):2097-107. PubMed ID: 16096823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute metabolic effects of adrenergic agents in swine.
    Mersmann HJ
    Am J Physiol; 1987 Jan; 252(1 Pt 1):E85-95. PubMed ID: 2880510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis.
    Farrer M; Fulcher GR; Johnson AJ; Record CO; Alberti KG
    Metabolism; 1992 May; 41(5):465-70. PubMed ID: 1588824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate.
    Fulcher GR; Walker M; Farrer M; Johnson AS; Alberti KG
    Metabolism; 1993 Mar; 42(3):308-14. PubMed ID: 8487648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of beta-adrenergic receptor stimulation and blockade on substrate metabolism during submaximal exercise.
    Mora-Rodriguez R; Hodgkinson BJ; Byerley LO; Coyle EF
    Am J Physiol Endocrinol Metab; 2001 May; 280(5):E752-60. PubMed ID: 11287358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Adrenoceptor-mediated thermogenesis and lipolysis in patients with chronic obstructive pulmonary disease.
    Schiffelers SL; Blaak EE; Baarends EM; Van Baak MA; Saris WH; Wouters EF; Schols AM
    Am J Physiol Endocrinol Metab; 2001 Feb; 280(2):E357-64. PubMed ID: 11158941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes.
    Saloranta C; Groop L; Ekstrand A; Franssila-Kallunki A; Eriksson J; Taskinen MR
    Diabet Med; 1993 Dec; 10(10):950-7. PubMed ID: 8306591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo beta3-adrenergic stimulation of human thermogenesis and lipid use.
    Schiffelers SL; Blaak EE; Saris WH; van Baak MA
    Clin Pharmacol Ther; 2000 May; 67(5):558-66. PubMed ID: 10824635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.